What makes a good RP?
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
In a recent blog, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) discusses possibilities (and expectations) for an effective appointment and training for the Responsible Person (RP) named on the Wholesale Distribution Authorisation (WDA).
The MHRA sees a number of "key areas" an RP and its employer should consider and which MHRA "will address in turn":
- Knowledge of GDP and the relevant regulations - this is the text book stuff.
- Industry experience - relevant GDP experience.
- Familiarity with the GDP operations of the Licence Holder - particularly challenging in a large organisation.
- Induction/primary training - role familiarity.
- Role definition and place within the organisation - sufficient seniority and influence.
- Delegation and training others - The RP is responsible for all GDP activities, even those delegated.
- Training records - RP, Licence Holder and staff.
- Continuing development for the RP - the supply chain continually presents new challenges.
Source: Quelle: MHRA Inspectorate Blog "The Responsible Person named on the WDA -Part 2: Effective Appointment and Training".
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates